Cork-based enterprise software firm Qumas, which develops compliance software for the pharmaceutical and finance sectors, has forged an alliance with Microsoft through the unveiling of a version of its flagship software that would be compatible on Microsoft’s SQL Server 2000 system.
Qumas’ eDocCompliance is an application that manages the full life cycle of regulatory and corporate documentation in compliance with the Federal Drugs Administration and the ISO and other international regulations, including the Sarbanes-Oxley Act.
The technology is used enterprise-wide by over 100 of the world’s leading regulated companies, including Astra-Zeneca, Roche Diagnostics and Vistakon.
The increasing level of regulation and enforcement within the life sciences sector has resulted in increasing demands for enterprise compliance management solutions along with appropriate platform technologies to manage and control the vast amounts of regulatory information generated during a product’s life cycle.
“Launching eDocCompliance for Microsoft SQL Server was a logical step for Qumas”, said the company’s CEO Paul Hands. “As a result of our open platform product development strategy, we can now provide eDocCompliance solution to life sciences companies running Microsoft SQL Server, renowned for its performance, scalability and reliability.”
The business and marketing officer of Microsoft Ireland, Leon McCarthy, added: “Microsoft SQL Server 2000 meets the most demanding data base and business intelligence needs and we are delighted that Qumas has introduced its eDocCompliance solution for this platform.”
By John Kennedy